Bengaluru, December 1, 2024 A groundbreaking milestone in cancer treatment was achieved today with the successful hosting of a landmark conference on Cytotron Technology. Organized by Glia Integrated Healthcare and Akshaya Neuro & Multi Speciality Hospital, in collaboration with Organization de Scalene, the event took place at Hotel Hilton, Bangalore.
This pioneering technology, recognized as a USFDA Designated Breakthrough, is poised to transform cancer care offering a safer, non-toxic and more effective treatment option for patients. Themed Next-Gen Cancer Care: Cytotron, the Safest FRB Cytostatic Radiation, the conference brought together the brightest minds in oncology, featuring a stellar lineup of speakers, including:
Dr. Rajah Vijaya Kumar, Inventor of Cytotron
Dr. Lim Yew Cheng, Consultant Cardiothoracic Surgeon, MOB Gleneagles, Kuala Lumpur, Malaysia
Prof. Meena Augustus, CEO & Chief Scientific Officer, Shreis Scalene, USA
Dr. Deepak Rautray, Surgical Oncologist & Director, AHPGIC, Cuttack, Odisha
The Hon’ble Minister of Health and Family Welfare, Government of Karnataka, Shri Dinesh Gundu Rao, graced the event as the Chief Guest. In his inaugural speech, he lauded the efforts of the organizing institutions in bringing a globally relevant technology to the forefront.
Dr. Anjana Nair, Medical Director of Glia Integrated Healthcare, welcomed the dignitaries, emphasizing the importance of collaboration in advancing cancer care.
Dr. Rajah Vijaya Kumar, the visionary behind Cytotron technology, remarked, “Cytotron represents a paradigm shift in cancer treatment, offering targeted solutions that minimize harm to healthy tissues. Our mission is to make this breakthrough accessible to millions, transforming the fight against cancer.”
Adding a global perspective, Dr. Lim Yew Cheng stated, “The efficacy of Cytotron Technology in managing cancer and degenerative conditions is unparalleled. Its a beacon of hope, not just for patients but for the entire medical community.”
Prof. Meena Augustus highlighted the scientific underpinnings, noting,
“Cytotron’s ability to modulate cellular behavior at a quantum level opens up avenues for treating diseases we once thought insurmountable. This is not just innovation; it is the future of healthcare.”
Dr. Deepak Rautray shared insights from his clinical expertise, saying,
“As an oncologist, I see Cytotron as a game-changer, particularly in cases where conventional treatments fall short. Its precision and safety profile are unmatched.”
Dr. Raghu Pillai, Managing Director of Glia Integrated Healthcare, said
“This conference is a significant milestone, bringing together the best minds in oncology to explore and promote Cytotron Technology. We are committed to its adoption and awareness, as it holds the potential to redefine cancer care globally.”
Shri. Rigesh T.V, Managing Director of Akshaya Neuro and Multi Specialty Hospital, concluded “Akshaya Neuro and Multi Speciality Hospital is a leading healthcare institution in Bangalore, India. With a strong commitment to delivering exceptional patient care, Akshaya Neuro and Multi Speciality Hospital offers a comprehensive range of medical services, including neurology, neurosurgery, oncology, and more. In our pursuit of innovative and effective treatment options, we introduced Cytotron Technology at our hospital. By adopting this cutting-edge technology, we aim to provide our patients with access to the latest advancements in cancer care, improving their treatment outcomes and quality of life.”
City Today News 9341997936
City Today News 